Episode Details
Back to EpisodesClinical update with Dr. Daniel Griffin
Description
In his weekly clinical update, Dr. Griffin with Vincent Racaniello debate the changes in FDA vaccine approval policy especially how it is applied to COVID-19 vaccines and restricts vaccine availability/usage and Novavax’s vaccine, mpox on surfaces and in the air, “bird flu”, the ongoing measles outbreak globally before Dr. Griffin reviews recent statistics on RSV, benefits of vaccination for infants, influenza and SARS-CoV-2 infections, the Wasterwater Scan dashboard, the high number of childhood deaths during this “flu” season, the May 22 VRBPAC COVID-19 vaccine meeting, where to find PEMGARDA, prolonged steroid and antibiotic therapies, provides information for Columbia University Irving Medical Center’s long COVID treatment center, where to go for answers to your long COVID questions, cognitive impairment in long COVID and contacting your federal government representative to stop the assault on science and biomedical research.
Subscribe (free): Apple Podcasts, RSS, emailBecome a patron of TWiV!
Links for this episode- FDA to issue new vaccine approval guidance amid questions over coronavirus shots (Washington Post)
- FDA vaccine committee meeting(Reuters)
- Evidence-based approach to COVID-19 vaccination (NEJM)
- FDA CBER townhall: new COVID019 vaccination approval mechanism (YouTube)
- FDA poised to restrict access to COVID vaccines, our own Dr. Griffin is cited! (NY Times)
- Novavax approval letter (FDA)
- We giveth and taketh away: Novavax approved but restricted use (AP News)
- FDA approves Novavax COVID vaccine with stricter new conditions (NY Times)
- History behind public health falsehoods– vaccine and autism (NPR)
- Making vaccines less accessible-RFK Jr making MAHA! (PBS News Hour)
- Kenneday says DO NOT to take medical advice from him, the HHS secretary…hummmm (NY Times)
- Staying up to date with COVID-19 vaccines (CDC: COVID-19)
- How science lost America’s trust and surrendered health policy to skeptics (WSJ)
- HHS stops recommendation of COVID-19 sho